[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344882-105":59,"doc-detail-344882-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","styk1-expression-in-breast-cancer-and-its-association-with-vascular-invasion-and-clinicopathological-features","STYK1 expression in breast cancer and its association with vascular invasion and clinicopathological features","","STYK1 expression is evaluated as a potential molecular contributor to breast cancer progression through vascular invasion. Immunohistochemistry assessed STYK1 levels in formalin-fixed paraffin-embedded tissue from 220 primary breast carcinomas, with immunohistochemical scoring correlated to clinicopathological parameters and 10-year survival. Higher STYK1 expression appeared in invasive versus normal and non-invasive tumors and was significantly associated with vascular invasion, lymph node metastasis, estrogen receptor positivity, non-triple-negative phenotype, and locoregional recurrence, but not with tumor size, grade, distant metastasis, or overall survival.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/styk1-expression-in-breast-cancer-and-its-association-with-vascular-invasion-and-clinicopathological-features/344882/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/styk1-expression-in-breast-cancer-and-its-association-with-vascular-invasion-and-clinicopathological-features/344882.png","ImageObject",300,407,{"name":92,"@type":93},"Ava Thompson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main objective of the study?","Question",{"text":112,"@type":113},"To determine STYK1 expression level and pattern in breast cancer tissues and evaluate its association with clinicopathological features and patient outcome.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was STYK1 expression measured?",{"text":117,"@type":113},"STYK1 protein levels were assessed using immunohistochemistry on representative formalin-fixed paraffin-embedded tissue sections with STYK1 antibodies.",{"name":119,"@type":110,"acceptedAnswer":120},"Which clinical features showed significant association with high STYK1 expression?",{"text":121,"@type":113},"Higher STYK1 expression was significantly linked to vascular invasion, lymph node metastasis, estrogen receptor positivity, a non-triple-negative phenotype, and locoregional recurrence.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},344882,1790301127,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":19,"preview_urls":144},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nSTYK1 expression in breast cancer and its association with vascular invasion and clinicopathological features  \nRabab Mohammed1,4􀀍, Amina Ismaeel1, Safa Alshaikh2, Aalaa Mubarak2, Sajedah Sabt3 & Samvel Selvam1  \nVascular invasion (VI) is an essential step in the progression of breast cancer (BC) and is a key factor behind morbidity and mortality. In a previous work using gene expression profiling, upregulation of STYK1 was one of the genetic changes that was found associated with VI. The aims ofthe following study were to assess (1) level and pattern of STYK1 expression in BC tissues and (2) its association with clinicopathological features and with patient outcome. Histopathological, clinical data and 10‒year survival data for 220 primary breast carcinoma was retrieved. From each specimen, one representative formalin-fixed paraffin-embedded tissue section was stained by immunohistochemistry (IHC) with STYK1 antibodies. IHC score was calculated and correlated with clinicopathological features of tumors. Higher STYK1 expression was detected in invasive BC compared with normal and non-invasive tumors, P = 0.001 and was significantly associated with the presence of vascular invasion (P = \u003C0.001), lymph node metastasis (P = 0.032) estrogen receptor positivity (P = 0.033), non‒triple negative phenotype (P = \u003C0.018) and occurrence of locoregional recurrence (P = 0.011) . No association was detected with other tumor features such as tumor size, grade, development of distant metastasis or overall survival. STYK1 is expressed at a higher level in invasive BC compared with non-cancerous tissues. This high expression is significantly associated with presence of VI, LN metastasis and occurrence of recurrence. These findings suggest that STYK1 could be a possible molecular target for breast carcinoma. Targeted therapy that can inhibit STYK1 kinase can be a possible approach for the development of novel therapies in breast carcinoma.  \nKeywords Breast cancer, STYK1, Vascular invasion clinicopathological features  \nAbbreviations  \nER PREGF  \nPDGF/FGF  \nTN breast cancer IHC  \nLN status  \nEstrogen receptor Progesterone Receptor Epidermal growth factor  \nProteins and platelet-derived growth factor/fibroblast growth factor  \ntriple negative breast cancer Immunohistochemistry Lymph node status  \nVascular invasion is an essential step in the progression of any malignant tumor including breast cancer. Through VI, malignant cells spread to remote sites establishing new tumor deposits in distant organs causing tissue destruction and function deterioration which is the key factor behind morbidity and mortality of breast cancer. In previous work, we could identify genetic changes associated with the ability of breast cancer to invade tumor vasculature1. Upregulation of STYK1 was one of the genetic alterations that came on top of these genetic changes. However, data about STYK1 expression in human breast cancer tissues or its association with clinicopathological features and clinical outcome is limited with some controversial findings among studies.  \n1Department of Pathology, Faculty of Medicine and Health Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain. 2Department of Pathology, Salmaniya Medical Complex, Manama, Kingdom of Bahrain. 3Department of Oncology, Salmaniya Medical Complex, Manama, Kingdom of Bahrain. 4Department of Pathology, Faculty of Medicine, Assiut University, Assiut, Egypt. 􀀍 email: [rababam@agu.edu.bh](rababam@agu.edu.bh); rabab_[aamh@yahoo.com](aamh@yahoo.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nSTYK1 is an oncogenic protein that belongs to the receptor tyrosine kinase (RTK) family. Members of this family are cell surface receptors. These receptors become activated when they bind the relevant growth factors, cytokines or hormones2. Among the well-known groups of this family are the epidermal growth ","cbCait4MVFAjR0Yd","https://ap.wps.com/l/cbCait4MVFAjR0Yd","pdf",1763347,"English","# Study background\n## Role of vascular invasion in breast cancer\n## STYK1 as an oncogenic receptor tyrosine kinase\n# Rationale and prior evidence\n## Findings across other cancers\n## Limited and controversial breast cancer evidence\n# Study aims\n## Assess STYK1 expression level and pattern\n## Link expression to clinicopathological features and outcomes","[{\"question\":\"What was the main objective of the study?\",\"answer\":\"To determine STYK1 expression level and pattern in breast cancer tissues and evaluate its association with clinicopathological features and patient outcome.\"},{\"question\":\"How was STYK1 expression measured?\",\"answer\":\"STYK1 protein levels were assessed using immunohistochemistry on representative formalin-fixed paraffin-embedded tissue sections with STYK1 antibodies.\"},{\"question\":\"Which clinical features showed significant association with high STYK1 expression?\",\"answer\":\"Higher STYK1 expression was significantly linked to vascular invasion, lymph node metastasis, estrogen receptor positivity, a non-triple-negative phenotype, and locoregional recurrence.\"}]","STYK1 expression in breast cancer and its association with vascular invasion and clinicopathological features | PDF",1790055544,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6a7162f3d4fcac08d57118912b170aab.webp",983,1291,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/042018a28574c1cba331f433ebf1fb17.webp",982,1290,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f985766dfd247d40c7468e020b2e0431.webp",981,1289,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/effe82e3b0caf89e76cffaaa555a6043.webp",980,1287]